Kyverna Therapeutics, Inc., a biopharmaceutical company based in Emeryville, California, announced that it will present topline results from its registrational Phase 2 clinical trial, known as...
Kyverna Therapeutics, Inc. has announced plans to present topline results from its registrational Phase 2 clinical trial, known as KYSA-8, assessing the efficacy of its investigational...